Feed Top Reports Pricing

⌘K

08:25:35·266d

ANALYSTRating

Zynex upgraded by Ladenburg Thalmann with a new price target

ZYXI· Zynex Inc.

Health Care

Original source

Companies

ZYXI
Zynex Inc.
Health Care

Recent analyst ratings

Aug 1UpdateLadenburg Thalmann$3.70
Aug 1UpdateH.C. Wainwright-
Mar 12UpdateRBC Capital Mkts$5.50
Mar 12UpdateLadenburg Thalmann-
Oct 16UpdateRBC Capital Mkts$13.00
Jan 6UpdatePiper Sandler$18.00

Related

SEC126d
Zynex Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Creation of a Direct Financial Obligation, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits
SEC129d
Zynex Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Events That Accelerate or Increase a Direct Financial Obligation, Regulation FD Disclosure, Financial Statements and Exhibits
PR129d
Zynex Financial Restructuring Puts Company on Path to Long-Term Success
INSIDER154d
SEC Form 3 filed by new insider Aronzon Paul
SEC157d
SEC Form 10-Q filed by Zynex Inc.
SEC157d
Zynex Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
PR157d
Zynex Reports Third Quarter 2025 Financial Results
PR161d
Zynex Announces Strategic Initiatives: Engagement of Province, Appointment of Paul Aronzon to Board of Directors, and Formation of Special Committee

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds

Top lists

Trending By market cap Active companies Analyst upgrades Insider purchases FDA approvals SEC filings Sectors Market reports

Company

About Pricing Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022